Market Place
Sourcing Support
Sharps Receives $30 Million Purchase Order for Prefillable Copolymer Syringes
13 Jun 2024 //
GLOBENEWSWIRE
Nephron Announces Hiring of Key Executives
24 Oct 2023 //
PR NEWSWIRE
CDMOs Nephron and Canton each raise hundreds of millions in financing
18 Sep 2023 //
ENDPTS
Nephron, Partners Announce $350 Million Capital Raise for Future Growth
15 Sep 2023 //
PR NEWSWIRE
Nephron Works to Resolve Nationwide Drug Shortage by Producing Vital Medications
08 Aug 2023 //
PR NEWSWIRE
Nephron Announces New President of 503B Outsourcing Facility
08 Jun 2023 //
PR NEWSWIRE
Nephron To Produce 0.5% Albuterol 5 mL, Alleviating Nationwide Shortage
31 May 2023 //
PR NEWSWIRE
Akorn`s closure pressures already strained supplies of albuterol
10 Mar 2023 //
FIERCE PHARMA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Nephron Pharmaceuticals Corporation on Health Canada Inspection List
03 Jan 2023 //
HEALTH CANADA
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement
13 Dec 2022 //
GLOBENEWSWIRE
Nephron and Sharps Form Manufacturing and Research Partnership
11 Nov 2022 //
CONTRACTPHARMA
Nephron and Sharps Announce Manufacturing and Research Partnership
10 Nov 2022 //
PRNEWSWIRE
Nephron SC Inc Receives FDA Warning Letter
27 Oct 2022 //
FDA
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Nephron recalls 2.1M drug doses, devices on sterility concerns
02 Jun 2022 //
FIERCEPHARMA
Nephron Launches New Syringe Presentation
31 Jan 2022 //
PRNEWSWIRE
NRx Pharma up 35% on supply arrangement for Zyesami
12 Oct 2021 //
SEEKINGALPHA
Nephron CEO Lou Kennedy, Governor McMaster Announce Launch of Nephron Nitrile
15 Jul 2021 //
PR NEWSWIRE
Nephron`s Generic Sterile Water for Injection Receives Approval In US
13 Feb 2021 //
FDA
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
PRNEWSWIRE
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
BIOSPACE
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
PRNEWSWIRE
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
22 Dec 2020 //
BIOSPACE
FDA ad watchdog slaps two pharmas with warning letters
07 Oct 2020 //
FIERCE PHARMA
Relief Therapeutics announces supply deals while awaiting COVID-19 trial data
30 Sep 2020 //
REUTERS
Nephron`s Generic Ketorolac Tromethamine Receives Approval In US
20 Aug 2020 //
FDA
Nephron Pharmaceuticals Corporation Announces Historic Expansion
10 Jul 2020 //
PRNEWSWIRE
Nephron, One Medical Partner to Offer COVID-19 Testing Services
21 May 2020 //
PR NEWSWIRE
Nephron Pharmaceuticals Corporation Partnership with National Medical Products
05 Dec 2019 //
PR NEWSWIRE
Enforcement Report - Week of November 6, 2019
06 Nov 2019 //
FDA
Enforcement Report - Week of October 30, 2019
30 Oct 2019 //
FDA
Nephron Pharma Leverages the GHX Exchange Platform Simplified Product Ordering
29 Apr 2019 //
PR NEWSWIRE
Nephron Pharma Chops Another 60 Jobs as it Transitions Out of Florida
22 Aug 2016 //
BIOSPACE
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation
14 Jun 2016 //
PR NEWSWIRE
Nephron Pharma Cuts Another 250 Employees At Orlando HQ
21 Jan 2016 //
BIOSPACE
Nephron Pharma Lays Off 180+ in Orlando, Hires 700 in South Carolina
29 Oct 2015 //
BIOSPACE
Nephron recalls Ipratropium Bromide due to Lack of Assurance of Sterility
21 Oct 2015 //
FDA
